Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
COVID Defense Act This bill rescinds specified defense appropriations and authorizes funding for manufacturing and delivering COVID-19 vaccines internationally.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Health Issues
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Referred to the Committee on Foreign Affairs, and in addition to the Committee on Appropriations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $510,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Client expense: $640,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Client expense: $770,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Client expense: $630,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
2023 · fourth_quarter · Health Issues
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Client expense: $620,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
2023 · third_quarter · Health Issues
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
Client expense: $720,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Defense
H.R. 669 - Restricting First Use of Nuclear Weapons Act of 2021 H.R. 1554 - Nuclear SLCM Ban Act of 2021 H.R. 2227 - ICBM Act H.R. 2509 - Selective Service Repeal Act of 2021 H.R. 2603 - To establish the policy of the United States regarding the no-first-use of nuclear weapons. H.R. 5461 - COVID Defense Act H.R. 5629 - SAFEGUARD Act of 2021 H.R. 7900 National Defense Authorization Act for FY 2023 H.R. 7621 Department of Defense Civilian Harm Transparency Act H.R. 7625 Protection of Civilians in Military Operations Act H.R. 7637 Values in Arms Export Act of 2022 H.R. 8255 Energy and Water Appropriations for FY23 H.R. 3333 - Upholding Human Rights Abroad Act H.R. 8280 - Preventing Terrorist Transfers to Afghanistan Act S. 595 - Nuclear SLCM Ban Act of 2021 S. 982 - ICBM Act S. 1139 - Selective Service Repeal Act of 2021 S. 1148 - Restricting First Use of Nuclear Weapons Act of 2021 S. 1219 - A bill to establish the policy of the United States regarding the no-first-use of nuclear weapons. S. 1473 - SAFEGUARD Act of 2021 S. 1862 - Smarter Approaches to Nuclear Expenditures Act S. 2019 - HALT Act of 2021 S. 3558 - Values in Arms Export Act of 2022 S.4107 - Department of Defense Civilian Harm Transparency Act S. 4108 - Protection of Civilians in Military Operations Act S. 4543 - National Defense Authorization Act for FY 2023 S. 4491 - Preventing Terrorist Transfers to Afghanistan Act Unnumbered House bill - Justice for Shireen Act Unnumbered Senate Bill - Streamline Pentagon Budgeting Act Unnumbered Senate Bill - Cull Unfunded Requirements Budget Act
Client expense: $1,000,000 · Firm income: Not reported
2022 · third_quarter · Defense
H.R. 669 - Restricting First Use of Nuclear Weapons Act of 2021 H.R. 1554 - Nuclear SLCM Ban Act of 2021 H.R. 2227 - ICBM Act H.R. 2509 - Selective Service Repeal Act of 2021 H.R. 2603 - To establish the policy of the United States regarding the no-first-use of nuclear weapons. H.R. 5461 - COVID Defense Act H.R. 5629 - SAFEGUARD Act of 2021 H.R. 7900 National Defense Authorization Act for FY 2023 H.R. 7621 Department of Defense Civilian Harm Transparency Act H.R. 7625 Protection of Civilians in Military Operations Act H.R. 7637 Values in Arms Export Act of 2022 H.R. 8255 Energy and Water Appropriations for FY23 H.R. 3333 - Upholding Human Rights Abroad Act H.R. 8280 - Preventing Terrorist Transfers to Afghanistan Act S. 595 - Nuclear SLCM Ban Act of 2021 S. 982 - ICBM Act S. 1139 - Selective Service Repeal Act of 2021 S. 1148 - Restricting First Use of Nuclear Weapons Act of 2021 S. 1219 - A bill to establish the policy of the United States regarding the no-first-use of nuclear weapons. S. 1473 - SAFEGUARD Act of 2021 S. 1862 - Smarter Approaches to Nuclear Expenditures Act S. 2019 - HALT Act of 2021 S. 3558 Values in Arms Export Act of 2022 S.4107 Department of Defense Civilian Harm Transparency Act S. 4108 Protection of Civilians in Military Operations Act S. 4543 National Defense Authorization Act for FY 2023 S. 4491 Preventing Terrorist Transfers to Afghanistan Act Unnumbered House Bill - Justice for Shireen Act Unnumbered Senate Bill - Streamline Pentagon Budgeting Act Unnumbered Senate Bill - Cull Unfunded Requirements Budget Act
Client expense: $1,000,000 · Firm income: Not reported
2022 · second_quarter · Defense
H.R. 669 - Restricting First Use of Nuclear Weapons Act of 2021 H.R. 1554 - Nuclear SLCM Ban Act of 2021 H.R. 2227 - ICBM Act H.R. 2509 - Selective Service Repeal Act of 2021 H.R. 2603 - To establish the policy of the United States regarding the no-first-use of nuclear weapons. H.R. 5461 - COVID Defense Act H.R. 7900 National Defense Authorization Act, 2023 H.R. 7621 Department of Defense Civilian Harm Transparency Act H.R. 7625 Protection of Civilians in Military Operations Act H.R. 8255 Energy and Water Appropriations for FY23 S. 595 - Nuclear SLCM Ban Act of 2021 S. 982 - ICBM Act S. 1139 - Selective Service Repeal Act of 2021 S. 1148 - Restricting First Use of Nuclear Weapons Act of 2021 S. 1219 - A bill to establish the policy of the United States regarding the no-first-use of nuclear weapons. S. 1862 - Smarter Approaches to Nuclear Expenditures Act S. 2019 - HALT Act of 2021 S.4107 Department of Defense Civilian Harm Transparency Act S. 4108 Protection of Civilians in Military Operations Act Unnumbered Senate bill - National Defense Authorization Act, FY 2023
Client expense: $1,000,000 · Firm income: Not reported
2022 · first_quarter · Defense
H.R. 669 - Restricting First Use of Nuclear Weapons Act of 2021 H.R. 1554 - Nuclear SLCM Ban Act of 2021 H.R. 2227 - ICBM Act H.R. 2509 - Selective Service Repeal Act of 2021 H.R. 2603 - To establish the policy of the United States regarding the no-first-use of nuclear weapons. H.R. 5461 - COVID Defense Act S. 595 - Nuclear SLCM Ban Act of 2021 S. 982 - ICBM Act S. 1139 - Selective Service Repeal Act of 2021 S. 1148 - Restricting First Use of Nuclear Weapons Act of 2021 S. 1219 - A bill to establish the policy of the United States regarding the no-first-use of nuclear weapons. S. 1862 - Smarter Approaches to Nuclear Expenditures Act S. 2019 - HALT Act of 2021
Client expense: $1,000,000 · Firm income: Not reported
2021 · fourth_quarter · Defense
H.R. 669 - Restricting First Use of Nuclear Weapons Act of 2021 H.R. 1554 - Nuclear SLCM Ban Act of 2021 H.R. 2227 - ICBM Act H.R. 2509 - Selective Service Repeal Act of 2021 H.R. 2603 - To establish the policy of the United States regarding the no-first-use of nuclear weapons. H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 H.R. 5461 - COVID Defense Act S. 595 - Nuclear SLCM Ban Act of 2021 S. 982 - ICBM Act S. 1139 - Selective Service Repeal Act of 2021 S. 1148 - Restricting First Use of Nuclear Weapons Act of 2021 S. 1219 - A bill to establish the policy of the United States regarding the no-first-use of nuclear weapons. S. 1862 - Smarter Approaches to Nuclear Expenditures Act S. 2019 - HALT Act of 2021 S. 2792 - National Defense Authorization Act for Fiscal Year 2022
Client expense: $1,000,000 · Firm income: Not reported
2021 · third_quarter · Defense
H.R. 669, Restricting First Use of Nuclear Weapons Act of 2021 H.R. 2603 To establish the policy of the United States regarding the no-first-use of nuclear weapons. H.R. 1554, Nuclear SLCM Ban Act of 2021 H.R. 2227, ICBM Act H.R. 2509, Selective Service Repeal Act of 2021 H.R. 4350, National Defense Authorization Act for Fiscal Year 2022 H.R.5461, COVID Defense Act S. 595, Nuclear SLCM Ban Act of 2021 S. 982, ICBM Act S. 1148, Restricting First Use of Nuclear Weapons Act of 2021 S.1219 - A bill to establish the policy of the United States regarding the no-first-use of nuclear weapons. S. 1862, Smarter Approaches to Nuclear Expenditures Act S. 2019, HALT Act of 2021 S.1139, Selective Service Repeal Act of 2021 S. 2792, National Defense Authorization Act for Fiscal Year 2022
Client expense: $1,000,000 · Firm income: Not reported
| Democratic |
| CA |
| Bonnie Watson Coleman | Democratic | NJ |
| Earl Blumenauer | Democratic | OR |
| Eleanor Holmes Norton | Democratic | DC |
| Grace F. Napolitano | Democratic | CA |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Ilhan Omar | Democratic | MN |
| Jake Auchincloss | Democratic | MA |
| James P. McGovern | Democratic | MA |
| Jared Huffman | Democratic | CA |
| Jerrold Nadler | Democratic | NY |
| Jesús G. "Chuy" García | Democratic | IL |
| Jimmy Gomez | Democratic | CA |
| John P. Sarbanes | Democratic | MD |
| Juan Vargas | Democratic | CA |
| Mark DeSaulnier | Democratic | CA |
| Nydia M. Velázquez | Democratic | NY |
| Peter A. DeFazio | Democratic | OR |
| Pramila Jayapal | Democratic | WA |
| Rashida Tlaib | Democratic | MI |
| Raúl M. Grijalva | Democratic | AZ |
| Ritchie Torres | Democratic | NY |
| Steve Cohen | Democratic | TN |
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE